FOSUN INTL's (HKG:0656) subsidiary issued positive profit alert

Fosun Pharma, a subsidiary of FOSUN INTL (HKG:0656) and whose A shares are listed and traded on the Shanghai Stock Exchange,issued positive profit alert and expected that the net profit attributable to shareholders of the listed company for the six months ended 30 June 2010 will increase by more than 50%, as compared to the same period of 2009.
 
The expected profit growth is primarily due to the profit increase contributed by the subsidiaries in, among others, the pharmaceutical manufacturing, research and development and the pharmaceutical business segments of Fosun Pharma, and the gain from the transfer of 9.56% equity interest in Shanghai Forte Land Co., Ltd., which will be recognised in the results of Fosun Pharma for the six months ended 30 June 2010.